KE3722A - Sustained release theophylline tablet having reduced bulk - Google Patents

Sustained release theophylline tablet having reduced bulk

Info

Publication number
KE3722A
KE3722A KE3722A KE372287A KE3722A KE 3722 A KE3722 A KE 3722A KE 3722 A KE3722 A KE 3722A KE 372287 A KE372287 A KE 372287A KE 3722 A KE3722 A KE 3722A
Authority
KE
Kenya
Prior art keywords
sustained release
reduced bulk
release theophylline
theophylline tablet
theophylline
Prior art date
Application number
KE3722A
Other languages
English (en)
Inventor
T David Stephen
Brooks Dana
E Gallian Claude
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of KE3722A publication Critical patent/KE3722A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KE3722A 1980-05-06 1987-03-31 Sustained release theophylline tablet having reduced bulk KE3722A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US24978781A 1981-04-01 1981-04-01

Publications (1)

Publication Number Publication Date
KE3722A true KE3722A (en) 1987-04-30

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3722A KE3722A (en) 1980-05-06 1987-03-31 Sustained release theophylline tablet having reduced bulk

Country Status (17)

Country Link
AT (1) AT380789B (fr)
AU (1) AU549299B2 (fr)
CA (1) CA1165241A (fr)
CY (1) CY1368A (fr)
DE (1) DE3117756A1 (fr)
DK (1) DK155976C (fr)
FI (1) FI811356L (fr)
FR (1) FR2484253A1 (fr)
GB (1) GB2078518B (fr)
HK (1) HK4288A (fr)
IE (1) IE51157B1 (fr)
IT (1) IT1209867B (fr)
KE (1) KE3722A (fr)
LU (1) LU83342A1 (fr)
NL (1) NL8102168A (fr)
SE (1) SE452550B (fr)
SG (1) SG30987G (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (fr) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Also Published As

Publication number Publication date
AU549299B2 (en) 1986-01-23
FR2484253B1 (fr) 1983-06-03
IT1209867B (it) 1989-08-30
AT380789B (de) 1986-07-10
IE810989L (en) 1981-11-06
DK155976B (da) 1989-06-12
CY1368A (en) 1987-08-07
DK200181A (da) 1981-11-07
CA1165241A (fr) 1984-04-10
SE8102814L (sv) 1981-11-07
FI811356L (fi) 1981-11-07
DK155976C (da) 1989-10-30
FR2484253A1 (fr) 1981-12-18
NL8102168A (nl) 1981-12-01
SG30987G (en) 1987-07-17
HK4288A (en) 1988-01-29
GB2078518B (en) 1984-04-11
IT8148406A0 (it) 1981-05-06
SE452550B (sv) 1987-12-07
GB2078518A (en) 1982-01-13
DE3117756A1 (de) 1982-04-29
IE51157B1 (en) 1986-10-15
DE3117756C2 (fr) 1992-11-26
LU83342A1 (fr) 1982-01-20
AU7020581A (en) 1981-11-12
ATA202081A (de) 1985-12-15

Similar Documents

Publication Publication Date Title
IT1096813B (it) Derivati dell'acido 1,2,3-tiadiazol-5-carbossilico,mezzi ad azione erbicida e regolatrice della crescita contenenti questi composti e procedimento per prepararli
IT8123026A0 (it) Derivati dell'idantoina, procedimento per la loro preparazione, e medicinali contenenti gli stessi.
HUT37614A (en) Process for producing piridazinamines of antiviral activity and pharmaceutical compositions containing them as active agents
ES8305285A1 (es) Procedimiento para la obtencion de polimerizados lineales basicos.
IT8219947A0 (it) Complessi platino-diamminici eprocedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi.
DK468288A (da) Antivirale forbindelser
IT1150639B (it) Preparazione di insulina stabilizzate e metodo per la loro produzione
LU80235A1 (fr) Analogues de la prostaglandine e1,compositions pharmaceutiques les contenant et procede de preparation
IT8221563A0 (it) Derivati della carbossimide, procedimenti per la loro produzione e medicinali contenenti glistessi.
BE892388A (fr) Derives d'un acide quinoleine-carboxylique procede pour les preparer et medicament en contenant
HK4288A (en) Sustained release theophylline tablet having reduced bulk
PT77581B (fr) Procede pour preparer et fabriquer des comprimes de theophyline a liberation controlee
FR2315267A1 (fr) Nouvelle 1,9-lactone du type prostaglandine, son procede de preparation et medicament la contenant
IT8019992A0 (it) Derivati dell'acido 3-fosfonocefalosporanico, procedimenti per la loro preparazione e composizione farmaceutica che li comprende.
ES8504127A1 (es) Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
FR2412312A1 (fr) 3-fluoro-10-piperazino-10,11-dihydrodibenzo-(b,f)thiepines substituees en 8, leurs sels, et procede pour leur preparation
BE891557A (fr) Procede de preparation de comprimes analgesiques, directement compressibles, d'acetaminophene renfermant de la carboxyme-thylcellulose sodique et nouveaux produits ainsi obtenus
BE866488A (fr) Procede de dosage global d'hormones et de produits pharmaceutiques
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
ES468938A1 (es) Metodo de preparacion de auranofin.
IT7852360A0 (it) Procedimento per la produzione di derivati del tetraciclononano antivirali prodotto ottenuto e composizioni farmaceutiche che li contengono
BE894597A (fr) Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques les contenant et leur utilisation en medecine humaine
IE782540L (en) Tablets containing¹1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
JPS5430187A (en) Preparation of uracil derivative